샘플 요청 목록

 카트 문의
시장보고서
상품코드
1655419

세계의 신경혈관 스텐트 시장

Neurovascular Stents
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 179 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 신경혈관 스텐트 시장은 2030년까지 34억 달러에 달할 전망

2024년에 19억 달러로 추정되는 세계의 신경혈관 스텐트 시장은 2024-2030년에 CAGR 9.7%로 성장하며, 2030년에는 34억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 경동맥 스텐트는 CAGR 10.3%를 기록하며, 분석 기간 종료시에는 25억 달러에 달할 것으로 예측됩니다. 두개내 스텐트부문의 성장률은 분석 기간 중 CAGR 8.0%로 추정됩니다.

미국 시장은 추정 5억 4,870만 달러, 중국은 CAGR 9.0%로 성장 예측

미국의 신경혈관 스텐트 시장은 2024년에 5억 4,870만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 분석 기간인 2024-2030년의 CAGR 9.0%를 견인하며, 2030년에는 5억 1,150만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 8.7%와 7.8%로 예측됩니다. 유럽에서는 독일이 CAGR 약 7.7%로 성장할 것으로 예측됩니다.

세계의 신경혈관 스텐트 시장 - 주요 동향과 촉진요인 정리

신경혈관 스텐트는 무엇이며, 왜 뇌졸중 관리에 필수적인가?

신경혈관 스텐트는 뇌혈관 질환, 특히 허혈성 뇌졸중과 동맥류 예방 및 치료에 사용되는 특수 기구입니다. 이 작은 그물망 모양의 튜브는 동맥을 열어두거나 동맥류에서 혈류를 멀리 떨어뜨리기 위해 뇌 혈관 내에 삽입됩니다. 혈전이 뇌로 가는 혈류를 방해하는 허혈성 뇌졸중의 경우, 신경혈관 스텐트는 혈액순환을 회복하고 뇌의 영구적인 손상을 예방하기 위해 종종 사용됩니다. 동맥류의 경우, 흐름을 바꾸는 스텐트는 약해진 혈관벽에서 혈액을 멀리 떨어뜨려 파열 위험을 줄이는 효과적인 방법을 제공합니다.

신경혈관 스텐트는 보다 침습적이고 위험도가 높은 시술이 필요한 질환에 대한 최소 침습적 치료를 가능하게 하므로 매우 중요합니다. 스텐트가 동맥벽을 지지하고 시술 중 및 시술 후 붕괴를 방지하는 능력은 스텐트의 효과에 있으며, 매우 중요합니다. 이러한 스텐트의 사용은 환자의 예후를 개선하고 회복 시간을 단축하며 뇌졸중 재발 및 동맥류 파열의 위험을 크게 감소시킴으로써 뇌졸중 관리에 혁명을 일으키고 있습니다.

신경혈관 스텐트 시장은 어떻게 발전하고 있는가?

신경혈관 스텐트 시장은 더욱 정교하고 특수한 스텐트 디자인의 개발로 빠르게 발전하고 있습니다. 중요한 동향 중 하나는 복잡하고 넓은 경부 동맥류 치료에 널리 보급되고 있는 유량 전환 스텐트의 부상입니다. 기존 스텐트와는 달리, 유량 전환 스텐트는 동맥류에서 혈류를 우회시켜 혈관이 시간이 지남에 따라 치유될 수 있도록 하는 역할을 합니다. 이 혁신은 여러 번의 수술의 필요성을 줄이고, 과거에는 수술이 불가능하다고 여겨졌던 동맥류에 대해 보다 안전한 옵션을 제공할 수 있습니다.

또 다른 큰 발전은 자기 확장형 스텐트의 개발입니다. 이 스텐트는 환자의 혈관의 독특한 모양에 맞도록 설계되었습니다. 이 스텐트는 더 정밀하게 배치할 수 있고 동맥에 외상을 입힐 가능성이 적습니다. 또한 목적을 달성하면 점차 용해되는 생체흡수성 스텐트가 인기를 얻고 있습니다. 이러한 스텐트는 영구적 이식에 따른 장기적인 위험을 줄여주며, 특히 젊은 환자나 기존 금속 스텐트로 인한 합병증 위험이 높은 환자들에게 특히 유용합니다.

어떤 질환이 신경혈관 스텐트 사용을 촉진하는가?

신경혈관 스텐트의 채택은 주로 허혈성 뇌졸중과 뇌동맥류 치료의 필요성에 의해 주도되고 있습니다. 혈전이 뇌로의 혈류를 방해하는 허혈성 뇌졸중에서 스텐트 리트리버는 혈액 순환을 회복하고 장기적인 장애와 사망을 예방하는 데 중요합니다. 이 장비는 혈전을 기계적으로 제거하고 막힌 동맥을 재개통시켜 환자의 예후를 크게 개선할 수 있습니다. 신경혈관 스텐트는 경동맥 협착증 치료에도 사용됩니다. 경동맥 협착증은 경동맥이 좁아져 뇌로 가는 혈류를 제한하여 뇌졸중 위험을 높이는 질환입니다.

뇌동맥류는 스텐트 도입을 촉진하는 또 다른 중요한 질환입니다. 혈류 전환 스텐트는 기존의 코일링 기술로 치료하기 어려운 경부의 넓은 동맥류나 큰 동맥류를 치료하는 데 사용됩니다. 이 스텐트는 동맥류 파열의 위험을 줄이고 시간이 지남에 따라 혈관이 치유될 수 있는 최소 침습적 솔루션을 제공합니다. 또한 신경혈관 스텐트는 동정맥 기형(AVM)과 같은 혈관 기형 치료에도 사용되어 신경학 분야에서 그 용도가 더욱 확대되고 있습니다.

신경혈관 스텐트 시장의 주요 성장 촉진요인은?

신경혈관 스텐트 시장의 성장은 여러 가지 요인에 의해 이루어집니다. 특히 고령화 사회에서 허혈성 뇌졸중과 뇌동맥류 발생률 증가는 수요의 주요 원동력이 되고 있습니다. 또한 기존 수술보다 안전하고 신속하며 효과적인 치료 옵션을 제공한다는 이유로 저침습적 치료에 대한 선호도가 높아지면서 신경혈관 스텐트의 채택을 촉진하고 있습니다. 흐름 전환 기술 및 생체흡수성 재료와 같은 스텐트 설계의 기술 혁신은 이러한 장비의 안전성과 효능을 향상시켜 시장 성장을 가속하고 있습니다.

뇌졸중 예방에 대한 인식이 높아지고 조기 개입의 이점이 뇌졸중 관련 사망률을 낮추기 위한 정부의 구상과 함께 뇌졸중 예방에 대한 인식이 높아지면서 시장이 더욱 활성화되고 있습니다. 또한 의료 영상 및 실시간 내비게이션 기술의 발전으로 신경혈관 스텐트 치료의 정확도가 높아져 환자 예후가 개선되고 있습니다. 신흥 국가 시장의 의료 인프라 확대는 고급 신경혈관 치료 접근성을 높여 시장 성장에 기여하고 있습니다.

부문

제품 유형(경동맥 스텐트, 두개내 스텐트), 최종사용자(병원, 외래 수술센터)

조사 대상 기업의 예(주목 11사)

  • Abbott Laboratories
  • ACANDIS GmbH
  • Blockade Medical LLC
  • Cordis Corporation
  • InspireMD, Inc.
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • STI Laser Industries, Ltd.
  • Stryker Corporation
  • Terumo Medical Corporation
  • W. L. Gore & Associates

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장의 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

KSA 25.02.28

Global Neurovascular Stents Market to Reach US$3.4 Billion by 2030

The global market for Neurovascular Stents estimated at US$1.9 Billion in the year 2024, is expected to reach US$3.4 Billion by 2030, growing at a CAGR of 9.7% over the analysis period 2024-2030. Carotid Artery Stents, one of the segments analyzed in the report, is expected to record a 10.3% CAGR and reach US$2.5 Billion by the end of the analysis period. Growth in the Intracranial Stents segment is estimated at 8.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$548.7 Million While China is Forecast to Grow at 9.0% CAGR

The Neurovascular Stents market in the U.S. is estimated at US$548.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$511.5 Million by the year 2030 trailing a CAGR of 9.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.7% and 7.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.7% CAGR.

Global Neurovascular Stents Market - Key Trends & Drivers Summarized

What Are Neurovascular Stents and Why Are They Crucial in Stroke Management?

Neurovascular stents are specialized devices used to treat cerebrovascular conditions, particularly in the prevention and treatment of ischemic strokes and aneurysms. These small, mesh-like tubes are implanted in blood vessels in the brain to help keep arteries open or to redirect blood flow away from aneurysms. In cases of ischemic stroke, where blood clots block the flow of blood to the brain, neurovascular stents are often deployed to restore circulation and prevent permanent brain damage. For aneurysms, flow-diverting stents offer an effective way to redirect blood away from weakened vessel walls, reducing the risk of rupture.

Neurovascular stents are vital because they enable minimally invasive treatments for conditions that would otherwise require more invasive and higher-risk procedures. Their ability to support the artery walls and prevent collapse during and after the procedure is critical to their effectiveness. The use of these stents has revolutionized stroke management by improving patient outcomes, reducing recovery times, and significantly decreasing the risk of recurrent strokes or aneurysm ruptures.

How Is the Neurovascular Stents Market Advancing?

The neurovascular stents market is advancing quickly due to the development of more sophisticated and specialized stent designs. One of the key trends is the rise of flow-diverting stents, which are becoming increasingly popular for treating complex and wide-necked aneurysms. Unlike traditional stents, flow-diverters work by diverting blood flow away from the aneurysm, allowing the vessel to heal over time. This innovation reduces the need for multiple procedures and offers a safer alternative for aneurysms that were once considered inoperable.

Another significant advancement is in the development of self-expanding stents, which are designed to conform to the unique shape of the patient’s blood vessel. These stents can be deployed with greater precision and are less likely to cause trauma to the artery. Moreover, bioresorbable stents, which gradually dissolve after serving their purpose, are gaining traction. These stents reduce the long-term risks associated with permanent implants and are particularly beneficial in younger patients or those at higher risk for complications from traditional metal stents.

Which Conditions Are Driving the Adoption of Neurovascular Stents?

The adoption of neurovascular stents is primarily driven by the need to treat ischemic strokes and brain aneurysms. In ischemic strokes, where a blood clot obstructs blood flow to the brain, stent retrievers are critical in restoring circulation and preventing long-term disability or death. These devices allow for the mechanical removal of the clot and the reopening of the blocked artery, significantly improving patient outcomes. Neurovascular stents are also used in the treatment of carotid artery stenosis, a condition in which the carotid arteries narrow and restrict blood flow to the brain, increasing stroke risk.

Brain aneurysms are another key condition driving stent adoption. Flow-diverting stents are used to treat wide-necked or large aneurysms that are difficult to treat with traditional coiling techniques. These stents offer a minimally invasive solution that reduces the risk of aneurysm rupture and allows for vessel healing over time. Additionally, neurovascular stents are being used in treating vascular malformations such as arteriovenous malformations (AVMs), further expanding their applications in neurology.

What Are the Key Growth Drivers in the Neurovascular Stents Market?

The growth in the neurovascular stents market is driven by several factors. The increasing incidence of ischemic strokes and brain aneurysms, particularly among aging populations, is a primary driver of demand. Additionally, the growing preference for minimally invasive procedures is pushing the adoption of neurovascular stents, as they offer safer, faster, and more effective treatment options than traditional surgery. Technological innovations in stent design, such as flow-diversion technology and bioresorbable materials, are also fueling market growth by improving the safety and efficacy of these devices.

The rising awareness of stroke prevention and the benefits of early intervention, along with government initiatives to reduce stroke-related mortality, are further boosting the market. Moreover, advances in medical imaging and real-time navigation technologies are making neurovascular stent procedures more precise, enhancing patient outcomes. Expanding healthcare infrastructure in developing regions is also contributing to market growth by increasing access to advanced neurovascular treatments.

SCOPE OF STUDY:

The report analyzes the Neurovascular Stents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Carotid Artery Stents, Intracranial Stents); End-Use (Hospitals, Ambulatory Surgery Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 11 Featured) -

  • Abbott Laboratories
  • ACANDIS GmbH
  • Blockade Medical LLC
  • Cordis Corporation
  • InspireMD, Inc.
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • STI Laser Industries, Ltd.
  • Stryker Corporation
  • Terumo Medical Corporation
  • W. L. Gore & Associates

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Neurovascular Stents - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Stroke and Aneurysms Drives Demand for Neurovascular Stents in Minimally Invasive Treatments
    • Advancements in Stent Technology Propel Growth in Neurovascular Stents for Aneurysm Coiling and Clot Removal
    • Increasing Adoption of Flow Diversion Stents Expands Market for Aneurysm Management in Interventional Neurology
    • Growing Preference for Minimally Invasive Procedures Strengthens Demand for Neurovascular Stents in Stroke Treatment
    • Technological Innovations in Retrievable and Fully-Deployable Stents Accelerate Adoption in Complex Neurovascular Cases
    • Rising Use of Drug-Eluting Stents for Neurovascular Applications Expands Opportunities for Improved Patient Outcomes
    • Expansion of Stent-Assisted Coiling in Aneurysm Procedures Generates New Demand for Hybrid Neurovascular Devices
    • Increasing Focus on Patient-Specific Stents and Customized Solutions Drives Growth in Personalized Neurovascular Interventions
    • Growing Adoption of Bioabsorbable Stents Strengthens Market for Next-Generation Neurovascular Devices
    • Rising Prevalence of Cerebral Aneurysms in Aging Populations Expands Market for Neurovascular Stents in Elderly Care
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Neurovascular Stents Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Neurovascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Neurovascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Neurovascular Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Carotid Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Carotid Artery Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Carotid Artery Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Intracranial Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Intracranial Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Intracranial Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neurovascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: USA 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: Canada 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • JAPAN
    • Neurovascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Japan 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • CHINA
    • Neurovascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: China 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • EUROPE
    • Neurovascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Neurovascular Stents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Neurovascular Stents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Europe 15-Year Perspective for Neurovascular Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • FRANCE
    • Neurovascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: France 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 53: France Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • GERMANY
    • Neurovascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Germany Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Germany 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Italy Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Italy 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Neurovascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: UK Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: UK 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 71: UK Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 74: Rest of Europe Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Rest of Europe Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Rest of Europe 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Rest of Europe Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Rest of Europe 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Neurovascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 80: Asia-Pacific Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Asia-Pacific Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Asia-Pacific 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Asia-Pacific Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Asia-Pacific 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 86: Rest of World Recent Past, Current & Future Analysis for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of World Historic Review for Neurovascular Stents by Product Type - Carotid Artery Stents and Intracranial Stents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of World 15-Year Perspective for Neurovascular Stents by Product Type - Percentage Breakdown of Value Sales for Carotid Artery Stents and Intracranial Stents for the Years 2015, 2025 & 2030
    • TABLE 89: Rest of World Recent Past, Current & Future Analysis for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of World Historic Review for Neurovascular Stents by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of World 15-Year Perspective for Neurovascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제